Page last updated: 2024-08-24

1,7-phenanthroline and Immunologic Deficiency Syndromes

1,7-phenanthroline has been researched along with Immunologic Deficiency Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kempin, S; Pious, D; Stimac, E; Urieli-Shoval, S1
Müller-Eberhard, HJ1

Reviews

1 review(s) available for 1,7-phenanthroline and Immunologic Deficiency Syndromes

ArticleYear
Chemistry and reaction mechanisms of complement.
    Advances in immunology, 1968, Volume: 8

    Topics: Animals; Antibodies; Bacteria; Binding Sites; Cell Membrane; Complement System Proteins; Edetic Acid; Erythrocytes; Esterases; gamma-Globulins; Guinea Pigs; Hemoglobinuria, Paroxysmal; Hemolysis; Histamine Release; Humans; Immunochemistry; Immunologic Deficiency Syndromes; Iodine; Leukocytes; Mice; Molecular Weight; Peptide Hydrolases; Phagocytosis; Phenanthrolines; Rabbits; Rats; Terminology as Topic; Toxins, Biological

1968

Other Studies

1 other study(ies) available for 1,7-phenanthroline and Immunologic Deficiency Syndromes

ArticleYear
Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients.
    Journal of immunology (Baltimore, Md. : 1950), 1991, Jun-15, Volume: 146, Issue:12

    Topics: Cell Line; Chromosome Mapping; Genes, MHC Class II; HLA-DR Antigens; Humans; Immunologic Deficiency Syndromes; Mutation; Phenanthrolines; Promoter Regions, Genetic; Trans-Activators; Transfection

1991